SCHEMBL31023754

SCHEMBL31023754

O=C(O)N1CCC(N(c2ccc(F)cc2)c2ccc3c(c2)OCO3)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
TDP1 Q9NUW8 1/20 0.43
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 3/20 0.42
ATM Q13315 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
KMT2A Q03164 3/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
FAAH O00519 1/20 0.40
THRB P10828 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31023978 0.90 MGLL (0.47) ALDH1A1LMNASMN1; SMN2MAPTKMT2A
SCHEMBL31023784 0.85 SMN1; SMN2 (0.48) ALDH1A1SMN1; SMN2MAPTL3MBTL1RAB9A
SCHEMBL31023933 0.84 MEN1 (0.55) LMNAMAPTKMT2APOLBMEN1
SCHEMBL28613535 0.81 CYP3A4 (0.54) ATMRAB9ANPC1KMT2ACYP3A4
SCHEMBL31023963 0.78 CYP3A4 (0.43) ALDH1A1TDP1LMNASMN1; SMN2MAPT
SCHEMBL31023747 0.76 SCD5 (0.51) LMNAMAPTKMT2APOLBMEN1
SCHEMBL31023722 0.76 MGLL (0.49) MAPTKMT2ACYP3A4POLBMEN1
SCHEMBL28598203 0.75 CCR5 (0.49) NPC1KMT2ACYP3A4MEN1
SCHEMBL31023731 0.75 MGLL (0.48) KMT2AFAAHMGLL
SCHEMBL31023799 0.73 BMP1 (0.54) ALDH1A1SMN1; SMN2MAPTL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665718-A1 SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF Apogee Pharmaceuticals, Inc. (CA) 2025-12-24 EP disclosed
WO-2024168426-A1 SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF APOGEE PHARMACEUTICALS, INC. (CA) 2024-08-22 WO disclosed